This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: Winfried S Wels: Innovator in Antibody Development
Introduction
Winfried S Wels is a notable inventor based in Emmendingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of 2 patents, his work focuses on innovative solutions for diagnosing and treating pathological conditions.
Latest Patents
Wels' latest patents include advancements in epidermal growth factor receptor antibodies. The first patent relates to single and double chain antibodies to the EGF receptor, which are designed to be conjugated with toxins. These antibodies are particularly useful for treating and diagnosing conditions such as cancer and cellular hyperproliferation. The second patent mirrors this innovation, emphasizing the importance of these antibodies in medical diagnostics and therapeutics.
Career Highlights
Throughout his career, Winfried S Wels has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in antibody development and contribute to significant advancements in the field.
Collaborations
Wels has collaborated with various professionals, including Mathias Schmidt and Evangelia Vakalopoulou. These partnerships have fostered a collaborative environment that enhances innovation and research in antibody technology.
Conclusion
Winfried S Wels stands out as a key figure in the development of therapeutic antibodies, with a focus on addressing critical health challenges. His contributions continue to impact the field of biotechnology and medical research.